A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
University Hospital, Geneva
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GOG Foundation
Fox Chase Cancer Center
National Cancer Institute (NCI)
GOG Foundation
GOG Foundation
GOG Foundation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)